Standardization of intralesional meglumine antimoniate treatment for cutaneous leishmaniasis
Rev. Soc. Bras. Med. Trop
;
49(6): 774-776, Dec. 2016. graf
Artículo
en Inglés
| LILACS
| ID: biblio-1041383
ABSTRACT
Abstract INTRODUCTION:
Intralesional treatment for cutaneous leishmaniasis has been applied for over 30 years at the Oswaldo Cruz Foundation, Rio de Janeiro, with good therapeutic results and without relevant systemic toxicity. METHODS Meglumine antimoniate was injected subcutaneously, using a long medium-caliber needle (for example, 30mm × 0.8mm); patients received 1-3 injections, with 15-day intervals. RESULTS The technique is described in detail sufficient to enable replication.CONCLUSIONS:
The treatment of cutaneous leishmaniasis with intralesional meglumine antimoniate is a simple, effective, and safe technique, which may be used in basic healthcare settings.
Texto completo:
Disponible
Índice:
LILACS (Américas)
Asunto principal:
Compuestos Organometálicos
/
Leishmaniasis Cutánea
/
Meglumina
/
Antiprotozoarios
Límite:
Humanos
Idioma:
Inglés
Revista:
Rev. Soc. Bras. Med. Trop
Asunto de la revista:
Medicina Tropical
Año:
2016
Tipo del documento:
Artículo
País de afiliación:
Brasil
Institución/País de afiliación:
Fundação Oswaldo Cruz/BR
/
Secretaria Municipal de Saúde de Timóteo/BR
Similares
MEDLINE
...
LILACS
LIS